RPAM

Rhenman & Partners Asset Management Portfolio holdings

AUM $791M
1-Year Est. Return 12.81%
This Quarter Est. Return
1 Year Est. Return
+12.81%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.23B
AUM Growth
+$101M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
96
New
Increased
Reduced
Closed

Top Buys

1
+$23.6M
2
+$23M
3
+$18.1M
4
MRK icon
Merck
MRK
+$15.1M
5
RPRX icon
Royalty Pharma
RPRX
+$12.5M

Top Sells

1
+$50.1M
2
+$25.9M
3
+$23.4M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$20.6M
5
IMMU
Immunomedics Inc
IMMU
+$18.8M

Sector Composition

1 Healthcare 97.59%
2 Industrials 0.53%
3 Communication Services 0%
4 Consumer Discretionary 0%
5 Energy 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$53.6M 4.37%
500,000
+220,000
2
$44.7M 3.65%
510,000
-234,354
3
$43.9M 3.58%
600,000
-95,000
4
$37.5M 3.06%
320,000
+99,220
5
$36.8M 3%
105,000
-5,000
6
$36.3M 2.96%
220,000
+50,000
7
$30.4M 2.48%
180,000
+15,000
8
$29.1M 2.38%
140,000
-10,000
9
$28.7M 2.34%
420,000
+180,000
10
$28.1M 2.3%
360,533
+192,853
11
$27.2M 2.22%
115,000
+5,000
12
$25.7M 2.1%
80,000
-10,000
13
$23.8M 1.94%
58,000
-2,000
14
$23M 1.88%
+115,000
15
$23M 1.87%
460,000
16
$22.9M 1.87%
90,000
+23,333
17
$22.4M 1.83%
385,000
+95,000
18
$22M 1.79%
100,000
-14,311
19
$21.9M 1.79%
170,000
-70,000
20
$21.1M 1.72%
340,000
+50,000
21
$20.8M 1.69%
120,000
-289,600
22
$20.5M 1.67%
160,000
+15,000
23
$20.4M 1.67%
63,000
-7,000
24
$20.1M 1.64%
235,000
-75,000
25
$20M 1.63%
220,000
-20,000
1
2 3 4